Journal article
Advanced Glycation End Products Predict Loss of Renal Function and High-Risk Chronic Kidney Disease in Type 2 Diabetes.
Abstract
OBJECTIVE: To evaluate the association of a multicomponent advanced glycation end product (AGE) panel with decline in kidney function and its utility in predicting renal function loss (RFL) when added to routine clinical measures in type 2 diabetes.
RESEARCH DESIGN AND METHODS: Carboxymethyl and carboxyethyl lysine and methylglyoxal, 3-deoxyglucosone, and glyoxal hydroimidazolones were measured in baseline serum and plasma samples, …
Authors
Koska J; Gerstein HC; Beisswenger PJ; Reaven PD
Journal
Diabetes Care, Vol. 45, No. 3, pp. 684–691
Publisher
American Diabetes Association
Publication Date
March 1, 2022
DOI
10.2337/dc21-2196
ISSN
0149-5992